Mycotoxin Testing Market

[326 Pages Report] According to MarketsandMarkets, the mycotoxin testing market is projected to reach USD 2.3 billion by 2029 from USD 1.6 billion by 2024, at a CAGR of 6.7% during the forecast period in terms of value. The prevalence of mycotoxin contamination in various agricultural commodities, such as cereals, grains, nuts, spices, and dried fruits, necessitates regular testing to detect and mitigate risks throughout the supply chain. Moreover, the globalization of food supply chains has increased the complexity of food production and distribution, elevating the risk of mycotoxin contamination and emphasizing the need for comprehensive testing protocols.

To know about the assumptions considered for the study, Request for Free Sample Report

To know about the assumptions considered for the study, download the pdf brochure

Market Dynamics

Driver: Rise in Global Food Trade

The rise in the global food trade has significantly driven the mycotoxin testing market by increasing the complexity and scope of food supply chains. As food products cross international borders, they encounter diverse climates, storage conditions, and agricultural practices, heightening the risk of mycotoxin contamination. To ensure the safety and quality of food products traded globally, regulatory authorities impose stringent standards on mycotoxin levels, necessitating thorough testing throughout the supply chain. Food producers and exporters must comply with these regulations to access international markets, driving the demand for mycotoxin testing services.

Restraint: High cost

The high cost of mycotoxin testing presents a significant barrier to its widespread adoption in the food industry. This cost encompasses initial investments in specialized equipment, ongoing maintenance, labor expenses for trained personnel, and additional costs associated with sample collection and analysis. For small and medium-sized enterprises with limited financial resources, these expenses can be particularly burdensome, potentially compromising their ability to implement comprehensive testing protocols. Addressing this challenge requires efforts to develop cost-effective testing methodologies and improve efficiency to ensure that food safety standards are upheld without imposing undue financial strain on stakeholders.

Opportunity: Development of Rapid Testing Devices

One opportunity in the mycotoxin testing market lies in the development of portable and rapid testing devices. These innovative technologies would enable on-site testing, providing real-time results and reducing the need for sample transportation and laboratory analysis. This advancement could significantly enhance efficiency and accessibility to mycotoxin testing, particularly in remote or resource-limited areas, ultimately contributing to improved food safety and public health outcomes.

Challenge: Emergence of new mycotoxins

The challenge of the emergence of new mycotoxins poses a significant obstacle in the field of mycotoxin testing. As fungal species evolve and environmental conditions change, new mycotoxins may arise, presenting novel risks to food safety and human health. Detecting and mitigating these emerging mycotoxins requires continuous research and development efforts to understand their properties, prevalence, and potential health impacts. Additionally, adapting existing testing methodologies to accurately identify and quantify these new mycotoxins presents technical challenges.

Mycotoxin Testing Market Ecosystem

Key players within this market consist of reputable and financially robust mycotoxin testing manufacturers. These entities boast extensive industry tenure, offering diversified product portfolios, advanced technologies, and robust global sales and marketing networks. Prominent companies in this market include SGS Société Générale de Surveillance SA (Switzerland), Bureau Veritas (France), Intertek Group plc (UK), DSM-Firmenich (Netherlands), Eurofins Scientific (Luxembourg), ALS (Australia), Neogen Corporation (US), AsureQuality (New Zealand), Symbio Labs (Australia), Microbac Laboratories, Inc. (US), INSTITUT MERIEUX (France), Premier Analytics Services (UK), Charm Sciences (US), OMIC USA INC. (US), and Bio-Check(UK)Ltd. (UK).

In the type segment, deoxynivalenol is to grow at a consistent rate in the global mycotoxin testing market.

Deoxynivalenol (DON) is one of the most prevalent mycotoxins found in cereals, particularly wheat, barley, and maize, which are staple food and feed crops globally. The widespread occurrence of DON contamination in these commodities necessitates regular testing to ensure food and feed safety. Secondly, DON poses significant health risks to humans and animals, including gastrointestinal disturbances, immunotoxicity, and reduced feed intake and growth performance in livestock. The potential health impacts associated with DON contamination drive the demand for testing to mitigate these risks. Thirdly, regulatory agencies worldwide have established maximum limits for DON levels in food and feed products to protect public health. Compliance with these regulations requires thorough testing, further contributing to the demand for DON testing services

By sample type, food samples to grow at the highest rate in the mycotoxin testing market.

Food safety concerns among consumers and regulatory authorities have heightened awareness of the risks associated with mycotoxin contamination in food products. As a result, there is increased scrutiny and regulation of mycotoxin levels in food samples, necessitating comprehensive testing to ensure compliance with safety standards. Secondly, the globalization of food supply chains has expanded the reach of food products across borders, increasing the likelihood of mycotoxin contamination during production, storage, and transportation. This has led to a greater need for testing to identify and mitigate contamination risks throughout the supply chain.

In the technology segment, chromatography- & spectroscopy- based technology to grow at highest rate in the given forecast period.

Spectroscopy-based technologies include mass spectroscopy and tandem spectroscopy. Mass spectroscopy is used to determine the elemental composition of a sample or a molecule. Tandem spectroscopy technique is used in the detection of multi toxins such as trichothecenes, aflatoxins (B1, B2, G1, and G2), OTA, ZEA, fumonisins, and Alternaria toxins. These methods offer high sensitivity and specificity, allowing for the accurate detection and quantification of mycotoxins even at low concentrations. Secondly, chromatography and spectroscopy techniques provide excellent resolution, enabling the separation and identification of complex mixtures of mycotoxins and matrix components present in food and feed samples. This has led to higher adoption of chromatography- & spectroscopy- based technology in mycotoxin testing.

Europe to dominate the mycotoxin testing market during the forecast period.

In Europe, food safety policies have been emphasized by efforts from Control Laboratories (CLs), National Reference Laboratories (Knurls), and EU Reference Laboratories (EURLs). These authorities have played an important role in maintaining food standards and protecting consumer health by ensuring the quality of the food supply chain. Europe has a highly developed food safety infrastructure, including well-established laboratories and testing facilities equipped with advanced chromatography and spectroscopy-based technologies for mycotoxin analysis. This infrastructure supports comprehensive testing programs and ensures the accuracy and reliability of results. Additionally, Europe has a diverse and extensive agricultural industry, producing a wide range of crops that are susceptible to mycotoxin contamination, such as cereals, grains, nuts, and dried fruits. The prevalence of contamination in these commodities underscores the importance of testing to mitigate risks and ensure food safety.

Key Market Players

The key players in this market include SGS Société Générale de Surveillance SA (Switzerland), Bureau Veritas (France), Intertek Group plc (UK), DSM-Firmenich (Netherlands), Eurofins Scientific (Luxembourg), ALS (Australia), Neogen Corporation (US), AsureQuality (New Zealand), Symbio Labs (Australia), Microbac Laboratories, Inc. (US), INSTITUT MERIEUX (France), Premier Analytics Services (UK), Charm Sciences (US), OMIC USA INC. (US), and Bio-Check (UK) Ltd. (UK). These market participants are emphasizing the expansion of their footprint via agreements and partnerships. They maintain a robust presence in North America, Asia Pacific, South America, RoW, and Europe, and they are supported by manufacturing facilities and well-established distribution networks spanning these regions.

Want to explore hidden markets that can drive new revenue in Mycotoxin Testing Market?

Unlock Insights

Scope of the Report

This research report categorizes the mycotoxin testing market based on type, sample technology, and region.

Target Audience

• Mycotoxin testing traders, retailers, and distributors
• Mycotoxin testing manufacturers & suppliers
• Related government authorities, commercial research & development (R&D) institutions.
• Regulatory bodies, including government agencies and NGOs.
• Commercial research & development (R&D) institutions and financial institutions.
• Government and research organizations.
• Venture capitalists and investors.
• Technology providers to mycotoxin testing and mycotoxin testing companies.
• Associations and industry bodies. 

Mycotoxin Testing Market:

By Type

• Aflatoxins
• Ochratoxins
• Fumonisins
• Deoxynivalenol
• Trichothecenes
• Zearalenone
• Patulin
• Other types

By Sample

• Food
  • Cereals, Grains, and Pulses
  • Milk and Milk Products
  • Meat, Poultry, and Seafood
  • Nuts, Seeds, and Spices
  • Fruits and Vegetables
  • Other Food Type
• Feed
  • Cereals and Cereal-by Products
  • Seeds and Seed Products
  • Forage and Silage
  • Other Feed Type

By Technology

• Chromatography- & Spectroscopy- Based
  • High Performance Liquid Chromatography (HPLC)
  • Other Type
• Gas Chromatography
• Liquid Chromatography
• Coupled Chromatography
• Tandem Spectrometry
  • Immnuno-assay Based

By Region:

• North America
• Europe
• Asia Pacific
• South America
• Rest of the World (RoW)

Recent Developments

• In August 2023, ALS (Australia) disclosed the acquisition of the Proanaliz Group of Laboratories (Turkey), a prominent entity specializing in food testing. This acquisition empowers ALS to provide extensive coverage to the Turkish market, boasting a collective of nine laboratories alongside robust technical support services.
• In May 2023, Symbio Labs in Australia expanded its capabilities to accurately detect a range of mycotoxins at low concentrations. With detection sensitivity reaching parts per billion, Symbio Labs guarantees precise reporting even at minimal levels. This enhancement establishes Symbio Labs as one of the few in Australia capable of promptly and accurately identifying mycotoxins in grain, finished feed, and food items.
• In March 2023, SGS Société Générale de Surveillance SA (Switzerland) finalized the acquisition of Asmecruz's testing business and assets, previously operated by a cooperative of mussel producers in Boiro, Spain. This strategic decision is in line with SGS's objective to bolster its food services and laboratory infrastructure across Europe, particularly to meet the growing demand for nutrition, health, and wellness-related services. Furthermore, it reinforces SGS's footprint in Spain.

Frequently Asked Questions (FAQ):

To speak to our analyst for a discussion on the above findings, click Speak to Analyst